Roche keeps up DTC on Boniva while others cut - FiercePharma
Links shared publicly online about this topic.
- 449total visits
Roche keeps up DTC on Boniva while others cut - FiercePharma
Marketing osteoporosis drugs has grown more complicated since Merck's Fosamax went off patent a couple years ago. Now that there are low-cost alternatives to branded bisphosphonate treatments,... Read more...
View full resource at fiercepharma.com
Tags: Osteoporosis, Osteoporosis Medication, Drug, Fosamax, Boniva, Merck & Co.
Most Recently Shared on March 10, 2011 at 4:21 pm By:
Roche keeps up DTC on Boniva while others cut. http://bit.ly/f1uyti
Advertisement
